Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제 26 기) 2026년 01월 01일–2026년 03월 31일,” contains a full table of contents covering business overview, detailed financial statements, MD&A (이사의 경영진단 및 분석의견), audit opinions, board and shareholder information, and detailed notes. This is a comprehensive quarterly/interim report, not an announcement or summary. It therefore falls under the Interim/Quarterly Report category (Code: IR). Q1 2026
2026-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 85% confidence The document is a Korean fair disclosure (“공정공시”) titled “영업(잠정)실적” which provides preliminary quarterly operating and profitability figures (sales, operating profit, net profit) for Q1 2026 compared to prior periods. It contains key highlights only and is not a full interim report. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results). Q1 2026
2026-04-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and contains detailed resolutions and voting percentages for each agenda item, including approval status (‘가결’) and voting ratios. This corresponds to a declaration of shareholder vote outcomes at an AGM. Therefore, it fits the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 90% confidence The document is a formal Korean regulatory notice filed with the Financial Services Commission and KRX, detailing the appointment (“선임“) of a new outside director (“사외이사”). This is clearly an announcement of changes in the company’s board of directors. Therefore, it belongs to the “Board/Management Information” category (MANG).
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 25th fiscal year (2025), covering company overview, business details, financial statements, management discussion and analysis, and governance. It contains detailed financial data, audit information, and operational disclosures. It is clearly a full annual financial report, not an announcement or a summary, and fits the definition of a 10-K (Annual Report) in the provided schema. FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Chong Kun Dang Bio. It provides the audit opinion, key financial data, and auditor information for the fiscal year ending 2025-12-31. While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. Given the short length and the nature of the disclosure as a regulatory notification of the audit report submission, it fits the 'Audit Report / Information' (AR) category as it specifically details the audit opinion and financial summary. FY 2025
2026-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.